Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | AKT1 | P31749 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17307358 | 0.84 | MAPT (0.36) | AKT1 | |
| SCHEMBL17307357 | 0.70 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL8926236 | 0.69 | AKT1 (0.32) | AKT1 | |
| SCHEMBL13647772 | 0.65 | ACHE (0.37) | MEN1KMT2A | |
| SCHEMBL21058198 | 0.64 | CPT1A (0.35) | MEN1KMT2ATSHR | |
| SCHEMBL21961902 | 0.61 | SIRT2 (0.45) | — | |
| SCHEMBL23925129 | 0.60 | TSHR (0.32) | MEN1KMT2ATSHR | |
| SCHEMBL23925072 | 0.60 | TSHR (0.32) | MEN1KMT2ATSHR | |
| SCHEMBL21961906 | 0.59 | SIRT2 (0.42) | MEN1KMT2A | |
| Maleic Anhydride SCHEMBL404095 | 0.59 | TSHR (0.59) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9278899-B2 | Method for producing 3,5-dimethyldodecanoic acid; and 4-carboxy-3,5-Dimethyl-3,5-dodecadienoic acid | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-03-08 | — | — | US | disclosed |
| US-20150344395-A1 | METHOD FOR PRODUCING 3,5-DIMETHYLDODECANOIC ACID; AND 4-CARBOXY-3,5-DIMETHYL-3,5-DODECADIENOIC ACID | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344395-A1 | METHOD FOR PRODUCING 3,5-DIMETHYLDODECANOIC ACID; AND 4-CARBOXY-3,5-DIMETHYL-3,5-DODECADIENOIC ACID | ACMSD, DECR1, HPD | MEN1 1047/4885KMT2A 3728/4885TSHR 4403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.